| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.738 | 0.003 | 0.738 | Anesthetic general | 0.555 0.005 DBMET02453 0.711 0.003 DBMET02454 | ||
| 0.442 | 0.017 | 0.442 | Anticonvulsant | 0.175 0.103 DBMET02453 0.277 0.047 DBMET02454 | ||
| 0.423 | 0.025 | 0.452 | Cardiotonic | 0.452 0.02 DBMET02453 0.409 0.027 DBMET02454 | DBMET02453 | |
| 0.433 | 0.042 | 0.823 | Aldehyde oxidase inhibitor | 0.823 0.004 DBMET02453 0.583 0.021 DBMET02454 | DBMET02453 | |
| 0.404 | 0.059 | 0.404 | GABA C receptor rho-3 antagonist | 0.261 0.145 DBMET02454 | ||
| 0.304 | 0.022 | 0.364 | Diuretic | 0.364 0.015 DBMET02453 0.321 0.019 DBMET02454 | DBMET02453 | |
| 0.321 | 0.041 | 0.321 | Vasodilator | 0.285 0.054 DBMET02453 0.255 0.066 DBMET02454 | ||
| 0.354 | 0.085 | 0.412 | Immunosuppressant | 0.331 0.097 DBMET02453 0.412 0.058 DBMET02454 | DBMET02454 | |
| 0.27 | 0.039 | 0.27 | Growth hormone agonist | 0.244 0.045 DBMET02453 0.258 0.041 DBMET02454 | ||
| 0.299 | 0.07 | 0.299 | 5 Hydroxytryptamine release stimulant | 0.287 0.074 DBMET02453 | ||
| 0.244 | 0.055 | 0.287 | Peptidyltransferase inhibitor | 0.28 0.033 DBMET02453 0.287 0.03 DBMET02454 | DBMET02454 | |
| 0.189 | 0.004 | 0.189 | Ca(v)3.1 blocker | 0.087 0.042 DBMET02454 | ||
| 0.273 | 0.098 | 0.389 | Immunomodulator | 0.389 0.047 DBMET02454 | DBMET02454 | |
| 0.266 | 0.102 | 0.347 | Interleukin 2 agonist | 0.347 0.047 DBMET02453 0.229 0.144 DBMET02454 | DBMET02453 | |
| 0.211 | 0.047 | 0.211 | Tumour necrosis factor antagonist | 0.175 0.072 DBMET02454 | ||
| 0.175 | 0.02 | 0.299 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.299 0.006 DBMET02453 0.17 0.021 DBMET02454 | DBMET02453 | |
| 0.323 | 0.169 | 0.323 | Caspase 9 stimulant | 0.263 0.238 DBMET02453 0.305 0.188 DBMET02454 | ||
| 0.232 | 0.081 | 0.356 | DNA synthesis inhibitor | 0.356 0.029 DBMET02453 0.229 0.084 DBMET02454 | DBMET02453 | |
| 0.24 | 0.101 | 0.358 | Immunostimulant | 0.358 0.062 DBMET02453 0.229 0.105 DBMET02454 | DBMET02453 | |
| 0.217 | 0.078 | 0.23 | RNA-directed DNA polymerase inhibitor | 0.23 0.064 DBMET02453 0.205 0.093 DBMET02454 | DBMET02453 | |
| 0.171 | 0.034 | 0.171 | Adenylate cyclase stimulant | 0.167 0.039 DBMET02453 0.171 0.035 DBMET02454 | ||
| 0.144 | 0.01 | 0.144 | Prostaglandin EP2 antagonist | 0.072 0.031 DBMET02453 0.106 0.017 DBMET02454 | ||
| 0.165 | 0.032 | 0.165 | Ferrochelatase inhibitor | 0.108 0.063 DBMET02454 | ||
| 0.227 | 0.102 | 0.292 | Spasmolytic | 0.292 0.073 DBMET02453 0.204 0.116 DBMET02454 | DBMET02453 | |
| 0.184 | 0.063 | 0.221 | Succinate dehydrogenase inhibitor | 0.202 0.047 DBMET02453 0.221 0.035 DBMET02454 | DBMET02454 | |
| 0.126 | 0.005 | 0.126 | Elastase inhibitor | 0.081 0.016 DBMET02453 0.117 0.007 DBMET02454 | ||
| 0.125 | 0.007 | 0.125 | Leukocyte elastase inhibitor | 0.115 0.008 DBMET02454 | ||
| 0.206 | 0.089 | 0.31 | Cyclic AMP phosphodiesterase inhibitor | 0.31 0.038 DBMET02453 0.184 0.107 DBMET02454 | DBMET02453 | |
| 0.132 | 0.021 | 0.132 | Metalloproteinase-9 inhibitor | 0.102 0.031 DBMET02453 0.118 0.025 DBMET02454 | ||
| 0.126 | 0.02 | 0.126 | Interleukin 5 antagonist | 0.111 0.03 DBMET02453 0.115 0.028 DBMET02454 | ||
| 0.145 | 0.044 | 0.145 | Vanilloid 1 agonist | 0.115 0.1 DBMET02453 0.137 0.055 DBMET02454 | ||
| 0.161 | 0.06 | 0.161 | GABA C receptor rho-2 antagonist | 0.127 0.111 DBMET02454 | ||
| 0.101 | 0.005 | 0.101 | Dihydroorotate oxidase inhibitor | 0.059 0.03 DBMET02453 0.076 0.012 DBMET02454 | ||
| 0.114 | 0.022 | 0.114 | Glycine receptor antagonist | 0.083 0.052 DBMET02454 | ||
| 0.22 | 0.129 | 0.22 | Insulysin inhibitor | |||
| 0.155 | 0.067 | 0.155 | NOS3 expression enhancer | |||
| 0.123 | 0.036 | 0.123 | Anabolic | 0.091 0.077 DBMET02453 0.111 0.048 DBMET02454 | ||
| 0.208 | 0.121 | 0.208 | Tyrosine 3 hydroxylase inhibitor | 0.181 0.174 DBMET02453 0.188 0.158 DBMET02454 | ||
| 0.088 | 0.002 | 0.088 | Nicotinic acid receptor 2 antagonist | 0.034 0.008 DBMET02453 0.053 0.004 DBMET02454 | ||
| 0.088 | 0.003 | 0.088 | Kainate receptor agonist | 0.052 0.012 DBMET02453 0.075 0.004 DBMET02454 | ||
| 0.254 | 0.174 | 0.259 | Antibacterial | 0.259 0.168 DBMET02454 | DBMET02454 | |
| 0.13 | 0.051 | 0.13 | Microtubule formation inhibitor | 0.126 0.054 DBMET02453 0.123 0.058 DBMET02454 | ||
| 0.11 | 0.034 | 0.11 | Metalloproteinase-2 inhibitor | 0.096 0.04 DBMET02453 0.098 0.039 DBMET02454 | ||
| 0.115 | 0.042 | 0.115 | Prolactin inhibitor | |||
| 0.105 | 0.034 | 0.105 | Transcription factor NF kappa B stimulant | 0.103 0.036 DBMET02454 | ||
| 0.108 | 0.038 | 0.124 | Phosphodiesterase 6D inhibitor | 0.124 0.021 DBMET02453 0.088 0.082 DBMET02454 | DBMET02453 | |
| 0.219 | 0.152 | 0.219 | Transcription factor NF kappa B inhibitor | 0.201 0.168 DBMET02454 | ||
| 0.119 | 0.054 | 0.119 | GABA C receptor antagonist | 0.096 0.084 DBMET02454 | ||
| 0.11 | 0.046 | 0.11 | DNA directed RNA polymerase inhibitor | |||
| 0.071 | 0.008 | 0.074 | Nicotinic acid receptor agonist | 0.074 0.008 DBMET02454 | DBMET02454 | |
| 0.118 | 0.056 | 0.171 | Mucolytic | 0.171 0.022 DBMET02453 0.11 0.065 DBMET02454 | DBMET02453 | |
| 0.154 | 0.093 | 0.154 | Neurotensin receptor agonist | |||
| 0.082 | 0.023 | 0.082 | Androgen agonist | 0.057 0.045 DBMET02454 | ||
| 0.081 | 0.026 | 0.097 | Biliverdin reductase inhibitor | 0.097 0.019 DBMET02453 0.076 0.028 DBMET02454 | DBMET02453 | |
| 0.147 | 0.097 | 0.147 | Nitric oxide antagonist | 0.138 0.108 DBMET02454 | ||
| 0.064 | 0.014 | 0.064 | Kainate receptor antagonist | 0.05 0.021 DBMET02454 | ||
| 0.082 | 0.034 | 0.102 | Phosphodiesterase III inhibitor | 0.102 0.022 DBMET02453 0.07 0.044 DBMET02454 | DBMET02453 | |
| 0.054 | 0.007 | 0.078 | Uridine phosphorylase inhibitor | 0.078 0.004 DBMET02453 0.068 0.004 DBMET02454 | DBMET02453 | |
| 0.116 | 0.069 | 0.116 | Proteasome inhibitor | 0.098 0.09 DBMET02454 | ||
| 0.081 | 0.036 | 0.089 | Matrix metalloproteinase inhibitor | 0.089 0.032 DBMET02453 0.072 0.042 DBMET02454 | DBMET02453 | |
| 0.085 | 0.04 | 0.085 | GABA aminotransferase inhibitor | 0.078 0.049 DBMET02454 | ||
| 0.081 | 0.037 | 0.087 | Glycine receptor agonist | 0.075 0.046 DBMET02453 0.087 0.031 DBMET02454 | DBMET02454 | |
| 0.114 | 0.072 | 0.114 | Adenylate cyclase inhibitor | 0.111 0.075 DBMET02453 0.104 0.08 DBMET02454 | ||
| 0.067 | 0.027 | 0.091 | Ornithine carbamoyltransferase inhibitor | 0.091 0.018 DBMET02453 0.088 0.019 DBMET02454 | DBMET02453 | |
| 0.112 | 0.073 | 0.112 | Anesthetic local | 0.104 0.08 DBMET02454 | ||
| 0.103 | 0.064 | 0.103 | GABA C receptor agonist | |||
| 0.052 | 0.014 | 0.052 | Membrane dipeptidase inhibitor | 0.045 0.02 DBMET02453 0.051 0.015 DBMET02454 | ||
| 0.118 | 0.08 | 0.118 | Cyclooxygenase 3 inhibitor | |||
| 0.067 | 0.032 | 0.084 | Argininosuccinate synthase inhibitor | 0.084 0.024 DBMET02453 0.056 0.04 DBMET02454 | DBMET02453 | |
| 0.098 | 0.065 | 0.098 | GABA C receptor rho-1 antagonist | |||
| 0.047 | 0.015 | 0.047 | Nicotinic acid receptor 2 agonist | 0.038 0.023 DBMET02454 | ||
| 0.076 | 0.044 | 0.15 | Phosphofructokinase-1 inhibitor | 0.15 0.018 DBMET02453 0.11 0.028 DBMET02454 | DBMET02453 | |
| 0.136 | 0.105 | 0.16 | Arachidonic acid antagonist | 0.146 0.093 DBMET02453 0.16 0.077 DBMET02454 | DBMET02454 | |
| 0.107 | 0.077 | 0.107 | TRPA1 agonist | |||
| 0.077 | 0.048 | 0.091 | Glutamate dehydrogenase inhibitor | 0.091 0.036 DBMET02453 0.073 0.052 DBMET02454 | DBMET02453 | |
| 0.095 | 0.067 | 0.298 | UDP-glucose 4-epimerase inhibitor | 0.298 0.01 DBMET02453 0.115 0.047 DBMET02454 | DBMET02453 | |
| 0.27 | 0.245 | 0.27 | Antiinflammatory | |||
| 0.174 | 0.15 | 0.184 | Superoxide dismutase inhibitor | 0.171 0.155 DBMET02453 0.184 0.136 DBMET02454 | DBMET02454 | |
| 0.092 | 0.068 | 0.105 | Xanthine oxidase inhibitor | 0.105 0.056 DBMET02454 | DBMET02454 | |
| 0.033 | 0.009 | 0.033 | DNA polymerase III inhibitor | 0.027 0.024 DBMET02453 0.032 0.011 DBMET02454 | ||
| 0.131 | 0.108 | 0.132 | Interferon gamma antagonist | 0.132 0.107 DBMET02454 | DBMET02454 | |
| 0.045 | 0.023 | 0.075 | Thymidine kinase inhibitor | 0.075 0.009 DBMET02453 0.061 0.013 DBMET02454 | DBMET02453 | |
| 0.096 | 0.074 | 0.109 | Adenylate kinase inhibitor | 0.109 0.054 DBMET02453 0.096 0.074 DBMET02454 | DBMET02453 | |
| 0.049 | 0.027 | 0.049 | Adenylate cyclase 1 inhibitor | |||
| 0.078 | 0.057 | 0.078 | Chymotrypsin inhibitor | |||
| 0.069 | 0.05 | 0.069 | HIV-1 reverse transcriptase inhibitor | |||
| 0.071 | 0.053 | 0.071 | Cathepsin G inhibitor | |||
| 0.035 | 0.017 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.024 DBMET02453 | ||
| 0.139 | 0.122 | 0.139 | ATPase inhibitor | |||
| 0.029 | 0.013 | 0.036 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.036 0.007 DBMET02453 0.035 0.007 DBMET02454 | DBMET02453 | |
| 0.024 | 0.009 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.027 0.005 DBMET02453 0.022 0.01 DBMET02454 | DBMET02453 | |
| 0.033 | 0.018 | 0.033 | Cyclophilin A inhibitor | |||
| 0.066 | 0.052 | 0.066 | Exportin-1 inhibitor | |||
| 0.027 | 0.013 | 0.035 | Neutral endopeptidase inhibitor | 0.035 0.01 DBMET02453 0.023 0.014 DBMET02454 | DBMET02453 | |
| 0.089 | 0.075 | 0.089 | Alpha 2d adrenoreceptor antagonist | |||
| 0.085 | 0.071 | 0.085 | HIV-1 integrase (Overall Integration) inhibitor | 0.083 0.074 DBMET02454 | ||
| 0.185 | 0.172 | 0.199 | Gastrin inhibitor | 0.199 0.15 DBMET02453 | DBMET02453 | |
| 0.042 | 0.031 | 0.056 | Macrophage elastase inhibitor | 0.056 0.02 DBMET02453 | DBMET02453 | |
| 0.138 | 0.127 | 0.138 | Psychostimulant | |||
| 0.057 | 0.046 | 0.057 | Ca(v)3.2 blocker | |||
| 0.065 | 0.054 | 0.073 | MDM2 inhibitor | 0.073 0.031 DBMET02453 0.064 0.059 DBMET02454 | DBMET02453 | |
| 0.188 | 0.177 | 0.188 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.015 | 0.005 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.005 DBMET02454 | ||
| 0.072 | 0.061 | 0.166 | Keratolytic | 0.166 0.012 DBMET02453 0.091 0.037 DBMET02454 | DBMET02453 | |
| 0.015 | 0.005 | 0.015 | Calcineurin inhibitor | |||
| 0.047 | 0.037 | 0.048 | CC chemokine receptor 2B antagonist | 0.048 0.035 DBMET02453 | DBMET02453 | |
| 0.025 | 0.016 | 0.025 | Glutamate (mGluR1) agonist | |||
| 0.053 | 0.045 | 0.053 | Fatty acid synthase inhibitor | |||
| 0.046 | 0.039 | 0.046 | HCV NS3/NS4A protease inhibitor | |||
| 0.013 | 0.007 | 0.013 | Immunosuppressant Cyclosporine-like | 0.013 0.006 DBMET02453 | ||
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET02453 0.021 0.014 DBMET02454 | ||
| 0.025 | 0.02 | 0.027 | Thymidine phosphorylase inhibitor | 0.027 0.016 DBMET02453 0.024 0.022 DBMET02454 | DBMET02453 | |
| 0.05 | 0.045 | 0.05 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.028 | 0.025 | 0.028 | Glucocorticoid antagonist | |||
| 0.05 | 0.048 | 0.113 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.113 0.012 DBMET02453 0.065 0.03 DBMET02454 | DBMET02453 | |
| 0.041 | 0.039 | 0.045 | Antimetabolite | 0.045 0.035 DBMET02453 0.041 0.04 DBMET02454 | DBMET02453 | |
| 0.085 | 0.084 | 0.085 | Electrolyte absorption antagonist | |||
| 0.073 | 0.075 | 0.075 | Ornithine decarboxylase inhibitor | 0.075 0.073 DBMET02453 | DBMET02453 | |
| 0.085 | 0.088 | 0.14 | Expectorant | 0.14 0.039 DBMET02453 | DBMET02453 | |
| 0.2 | 0.202 | 0.443 | Histamine release inhibitor | 0.443 0.054 DBMET02453 | DBMET02453 | |
| 0.111 | 0.114 | 0.161 | Cell wall synthesis inhibitor | 0.161 0.055 DBMET02453 0.118 0.103 DBMET02454 | DBMET02453 | |
| 0.054 | 0.059 | 0.087 | Neutrophil collagenase inhibitor | 0.087 0.028 DBMET02453 | DBMET02453 | |
| 0.027 | 0.034 | 0.043 | Fumarate hydratase inhibitor | 0.043 0.017 DBMET02453 | DBMET02453 | |
| 0.178 | 0.187 | 0.308 | Cholesterol antagonist | 0.308 0.086 DBMET02453 0.222 0.146 DBMET02454 | DBMET02453 | |
| 0.041 | 0.056 | 0.058 | Acyl-CoA dehydrogenase inhibitor | 0.058 0.035 DBMET02453 | DBMET02453 | |
| 0.183 | 0.2 | 0.209 | Antithrombotic | 0.209 0.166 DBMET02453 | DBMET02453 | |
| 0.108 | 0.129 | 0.124 | Sphingosine 1-phosphate receptor 2 antagonist | 0.124 0.088 DBMET02453 | DBMET02453 | |
| 0.014 | 0.037 | 0.018 | Methylmalonyl-CoA mutase inhibitor | 0.018 0.013 DBMET02453 | DBMET02453 | |
| 0.033 | 0.059 | 0.052 | Ribonucleotide reductase inhibitor | 0.052 0.041 DBMET02453 | DBMET02453 | |
| 0.078 | 0.105 | 0.142 | Nav1.1 sodium channel blocker | 0.142 0.036 DBMET02453 | DBMET02453 | |
| 0.027 | 0.055 | 0.043 | Endothelin-converting enzyme inhibitor | 0.043 0.035 DBMET02453 | DBMET02453 | |
| 0.098 | 0.127 | 0.134 | Protein kinase stimulant | 0.134 0.08 DBMET02453 | DBMET02453 | |
| 0.129 | 0.158 | 0.138 | Phospholipase C inhibitor | 0.138 0.133 DBMET02453 | DBMET02453 | |
| 0.071 | 0.104 | 0.088 | Estrogen-related receptor beta agonist | 0.085 0.052 DBMET02453 0.088 0.045 DBMET02454 | DBMET02454 | |
| 0.088 | 0.121 | 0.371 | Alpha-N-acetylglucosaminidase inhibitor | 0.371 0.01 DBMET02453 0.126 0.072 DBMET02454 | DBMET02453 | |
| 0.012 | 0.045 | 0.043 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.043 0.011 DBMET02453 | DBMET02453 | |
| 0.173 | 0.209 | 0.344 | Vasodilator, peripheral | 0.344 0.076 DBMET02453 | DBMET02453 | |
| 0.217 | 0.253 | 0.258 | Apoptosis agonist | 0.258 0.206 DBMET02454 | DBMET02454 | |
| 0.068 | 0.108 | 0.15 | NADH dehydrogenase inhibitor | 0.15 0.018 DBMET02453 | DBMET02453 | |
| 0.05 | 0.093 | 0.108 | Aminopeptidase I inhibitor | 0.108 0.024 DBMET02453 | DBMET02453 | |
| 0.064 | 0.109 | 0.129 | Protease inhibitor | 0.129 0.041 DBMET02453 | DBMET02453 | |
| 0.035 | 0.088 | 0.048 | Bombesin 2 receptor antagonist | 0.048 0.036 DBMET02453 | DBMET02453 | |
| 0.112 | 0.167 | 0.138 | Hepatoprotectant | 0.138 0.123 DBMET02453 | DBMET02453 | |
| 0.063 | 0.123 | 0.138 | Triose-phosphate isomerase inhibitor | 0.138 0.024 DBMET02453 0.082 0.073 DBMET02454 | DBMET02453 | |
| 0.031 | 0.093 | 0.069 | Glucose-6-phosphate isomerase inhibitor | 0.069 0.013 DBMET02453 | DBMET02453 | |
| 0.087 | 0.149 | 0.118 | Thrombolytic | 0.118 0.112 DBMET02453 0.117 0.114 DBMET02454 | DBMET02453 | |
| 0.056 | 0.119 | 0.134 | Aminopeptidase B inhibitor | 0.134 0.045 DBMET02453 | DBMET02453 | |
| 0.033 | 0.097 | 0.107 | Carbamoyl phosphate synthetase inhibitor | 0.107 0.018 DBMET02453 | DBMET02453 | |
| 0.119 | 0.187 | 0.148 | Platelet antagonist | 0.148 0.146 DBMET02454 | DBMET02454 | |
| 0.014 | 0.083 | 0.023 | Lysophosphatidic acid receptor 1 agonist | 0.023 0.021 DBMET02453 | DBMET02453 | |
| 0.021 | 0.095 | 0.054 | p53 inhibitor | 0.054 0.012 DBMET02453 | DBMET02453 | |
| 0.104 | 0.181 | 0.149 | Sphingosine 1-phosphate receptor 5 antagonist | 0.149 0.062 DBMET02453 | DBMET02453 | |
| 0.146 | 0.225 | 0.19 | Nitric-oxide synthase stimulant | 0.19 0.107 DBMET02453 | DBMET02453 | |
| 0.042 | 0.129 | 0.07 | Interferon inducer | 0.07 0.035 DBMET02453 | DBMET02453 | |
| 0.107 | 0.205 | 0.145 | Lipocortins synthesis antagonist | 0.145 0.113 DBMET02453 | DBMET02453 | |
| 0.032 | 0.133 | 0.117 | Catalase inhibitor | 0.117 0.034 DBMET02453 | DBMET02453 | |
| 0.072 | 0.181 | 0.11 | Nav1.2 sodium channel blocker | 0.11 0.096 DBMET02453 | DBMET02453 | |
| 0.143 | 0.252 | 0.3 | Vasodilator, coronary | 0.3 0.087 DBMET02453 | DBMET02453 | |
| 0.102 | 0.212 | 0.214 | Interleukin agonist | 0.214 0.108 DBMET02453 | DBMET02453 | |
| 0.015 | 0.128 | 0.059 | HIV-1 protease inhibitor | 0.059 0.012 DBMET02453 | DBMET02453 | |
| 0.043 | 0.161 | 0.096 | Interferon agonist | 0.096 0.032 DBMET02453 | DBMET02453 | |
| 0.057 | 0.18 | 0.122 | Nav1.3 sodium channel blocker | 0.122 0.072 DBMET02453 | DBMET02453 | |
| 0.094 | 0.222 | 0.16 | Hypolipemic | 0.16 0.127 DBMET02453 | DBMET02453 | |
| 0.02 | 0.156 | 0.076 | Alcohol oxidase inhibitor | 0.076 0.026 DBMET02453 | DBMET02453 | |
| 0.013 | 0.156 | 0.036 | Toll-Like receptor 2 agonist | 0.036 0.034 DBMET02453 | DBMET02453 | |
| 0.066 | 0.224 | 0.167 | Peroxidase inhibitor | 0.167 0.07 DBMET02453 | DBMET02453 | |
| 0.024 | 0.188 | 0.076 | Phenylalanine 4-hydroxylase inhibitor | 0.076 0.041 DBMET02453 | DBMET02453 | |
| 0.015 | 0.182 | 0.043 | Adenosine deaminase inhibitor | 0.043 0.037 DBMET02453 | DBMET02453 | |
| 0.179 | 0.347 | 0.398 | 5 Hydroxytryptamine release inhibitor | 0.398 0.079 DBMET02453 | DBMET02453 | |
| 0.039 | 0.226 | 0.081 | ATPase (Vacuolar H+) inhibitor | 0.081 0.076 DBMET02453 | DBMET02453 | |
| 0.047 | 0.235 | 0.122 | DNA polymerase I inhibitor | 0.122 0.067 DBMET02453 | DBMET02453 | |
| 0.119 | 0.335 | 0.293 | Sodium/bile acid cotransporter inhibitor | 0.293 0.086 DBMET02453 | DBMET02453 | |
| 0.017 | 0.234 | 0.064 | Alpha-mannosidase inhibitor | 0.064 0.022 DBMET02453 | DBMET02453 | |
| 0.042 | 0.268 | 0.133 | Amylase inhibitor | 0.133 0.073 DBMET02453 | DBMET02453 | |
| 0.014 | 0.256 | 0.069 | Neuraminidase (Influenza A) inhibitor | 0.069 0.007 DBMET02453 | DBMET02453 | |
| 0.011 | 0.263 | 0.049 | Mannosidase inhibitor | 0.049 0.026 DBMET02453 | DBMET02453 | |
| 0.012 | 0.309 | 0.062 | Selectin antagonist | 0.062 0.048 DBMET02453 | DBMET02453 | |
| 0.005 | 0.312 | 0.041 | Sphingosine 1-phosphate receptor 1 agonist | 0.041 0.031 DBMET02453 | DBMET02453 | |
| 0.01 | 0.336 | 0.111 | Neuraminidase inhibitor | 0.111 0.012 DBMET02453 | DBMET02453 | |
| 0.013 | 0.37 | 0.13 | Neuraminidase (influenza) inhibitor | 0.13 0.01 DBMET02453 | DBMET02453 | |
| 0.045 | 0.438 | 0.119 | Insulin secretagoues | 0.119 0.113 DBMET02453 | DBMET02453 | |
| 0.042 | 0.468 | 0.248 | Interleukin 6 antagonist | 0.248 0.023 DBMET02453 | DBMET02453 | |
| 0.003 | 0.529 | 0.033 | Sphingosine 1-phosphate receptor 3 agonist | 0.033 0.025 DBMET02453 | DBMET02453 | |
| 0.014 | 0.684 | 0.179 | Amyloid beta precursor protein antagonist | 0.179 0.073 DBMET02454 | DBMET02454 | |
| 0 | 0.775 | 0.018 | Mannitol 2-dehydrogenase inhibitor | 0.018 0.002 DBMET02453 | DBMET02453 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |